Increased epithelial membrane protein 2 expression in glioblastoma after treatment with bevacizumab is a research paper published in Neuro-Oncology Advances (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P50-CA211015
National Cancer Institute
Grant: R01 CA163971
National Institutes of Health
Grant: 5P50CA211015-02
UCLA SPORE in Brain Cancer
National Institutes of Health
Grant: 1R01CA163971-01A1
Using EMP2 for Image Guided Drug Delivery for Breast Cancer
NCI NIH HHS
Grant: P50 CA211015
FWCI
0.38
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals